P. Tumeh

发表

PD-1 blockade induces responses by inhibiting adaptive immune resistance

R. Emerson, C. Harview, A. Ribas, 2014, Nature.

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

T. Graeber, T. Schumacher, B. Comin-Anduix, 2016, The New England journal of medicine.

Antoni Ribas, A. Ribas, C. Radu, 2008, Journal of Nuclear Medicine.

Characteristic purpura of the ears, vasculitis, and neutropenia--a potential public health epidemic associated with levamisole-adulterated cocaine.

N. Craft, P. Tumeh, R. Birnbaum, 2011, Journal of the American Academy of Dermatology.

The Impact of Ex Vivo Clinical Grade Activation Protocols on Human T-cell Phenotype and Function for the Generation of Genetically Modified Cells for Adoptive Cell Transfer Therapy

T. Graeber, B. Comin-Anduix, A. Ribas, 2010, Journal of immunotherapy.

Cancer therapy: Tumours switch to resist

A. Ribas, P. Tumeh, 2012, Nature.

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

R. Dummer, A. Daud, O. Hamid, 2017, British Journal of Cancer.

Phase I Trial of Intratumoral Injection of CCL21 Gene–Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration

F. Marincola, F. Abtin, R. Suh, 2017, Clinical Cancer Research.

2 In fi ltration of CD 8 T Cells Q 1 and Expression of 3 PD-1 and PD-L 1 in Synovial Sarcoma Q 2 4

C. Denny, A. Ribas, B. Chmielowski, 2017 .

Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma

C. Denny, A. Ribas, B. Chmielowski, 2016, Cancer Immunology Research.

PD-1 Blockade Expands Intratumoral Memory T Cells

Dana Pe'er, Antoni Ribas, Juliet Frederiksen, 2016, Cancer Immunology Research.

Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes

R. Emerson, C. Harview, A. Ribas, 2014, Oncoimmunology.

Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes

S. Dry, Elizabeth Shurell, B. Chmielowski, 2016, Oncotarget.

Synthesis and biologic studies of iodinated (125I/127I) ethidium.

N. Ho, A. Kassis, P. Tumeh, 2001, Nuclear medicine and biology.

Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.

Antoni Ribas, Caroline Robert, Anthony M Joshua, 2013, The New England journal of medicine.

BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.

T. Graeber, A. Ribas, Stephen Mok, 2012, Cancer research.

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.

T. Graeber, L. Diaz, B. Comin-Anduix, 2017, Cancer discovery.

Primer on Cancer Immunotherapy and the Targeting of Native Proteins

P. Tumeh, Valentin V. Barsan, 2018 .

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

J. Taube, C. Harview, R. Dummer, 2017, Cancer Immunology Research.

Immunotherapy Resistance by Inflammation-Induced Dedifferentiation.

B. Comin-Anduix, A. Ribas, A. Cochran, 2018, Cancer discovery.

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials

H. Kohrt, J. Wolchok, L. Zitvogel, 2016, Journal of Immunotherapy for Cancer.

1 PD-1 blockade expands intratumoral T memory cells

D. Pe’er, A. Cornish, B. Comin-Anduix, 2016 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Enhanced skin toxicity with concurrent ipilimumab and radiation in vaginal/vulvar melanoma: a case report and literature review

G. Konecny, M. Kamrava, P. Tumeh, 2016, BJR case reports.

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

R. Dummer, O. Hamid, M. Levesque, 2017, British Journal of Cancer.

MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy.

Jonathan L. Schmid-Burgk, D. Schadendorf, J. Madore, 2017, Cancer research.

Clinical characteristics predictive of response to pembrolizumab in advanced melanoma.

A. Daud, M. Rosenblum, M. Krummel, 2015 .

Correlation between metastatic site and response to anti-Programmed Death-1 (PD-1) agents in melanoma.

R. Dummer, A. Daud, O. Hamid, 2016 .

Structural and functional imaging correlates for age-related changes in the brain.

Abass Alavi, Mohamed Houseni, Drew A Torigian, 2007, Seminars in nuclear medicine.

Abstract 2857: Metastatic site and response to pembrolizumab (anti-PD1 antibody) in melanoma

C. Harview, D. Elashoff, R. Pierce, 2015 .

Differentiation of vascular and non-vascular skin spectral signatures using in vivo hyperspectral radiometric imaging: Implications for monitoring angiogenesis

Jeremy M Lerner, Wafik S El-Deiry, W. El-Deiry, 2007, Cancer biology & therapy.

The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade

A. Ribas, P. Tumeh, 2014, Clinical Cancer Research.

Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC

J. Taube, C. Harview, R. Dummer, 2017, Cancer Immunology Research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Structural and functional imaging correlates for age-related changes in the brain.

A. Alavi, D. Torigian, A. Newberg, 2007, Seminars in nuclear medicine.